Constipation
Reports from Mayo Clinic add new data to research in constipation
Published in Gastroenterology Week, December 21st, 2009
"A multicentre, phase II, randomized, double-blind dose-escalation study in 89 elderly constipated nursing home residents treated with placebo, 0.5, 1 or 2 mg prucalopride once daily for 28 days was analysed. Adverse events, vital signs, ECG, Holter monitor and pharmacokinetics were assessed (Clinicaltrials.gov identifier: NCT00627692). Patients' mean age was 83 years; 88%...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
More Articles from Gastroenterology Week
- American Society for Gastrointestinal Endoscopy
ASGE issues guidelines on management of antithrombotic agents for endoscopic procedures - DOE/Lawrence Livermore National Laboratory
Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' - Journal of the National Cancer Institute
News brief: Dermatologic infections in cancer patients treated with EGFRI therapy - Santaris Pharma A/S
New data show breakthrough microRNA-targeted therapy holds promise as new treatment for hepatitis C - Scripps Research Institute
Scripps research team restores some function to cells from cystic fibrosis patients - Weber Shandwick Worldwide
Surgical quality program is a strong tool for assessing outcomes for high-risk procedures - More from this issue of Gastroenterology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
